Mohamed Raâfet Ben Khedher

Mohamed Raâfet Ben Khedher

Auto-generated profile, based on publicly available information

Mohamed Raâfet Ben Khedher

INRS Laval QC Canada

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in LWT
Verified
Journal Article
Closed access
JHJawhar Hafsa
Jawhar Hafsa
MSMed Ali Smach
Med Ali Smach
MKMed Raâfet Ben Khedher
Med Raâfet Ben Khedher
BCBassem Charfeddine
Bassem Charfeddine
KLKhalifa Limem
Khalifa Limem
SRSonia Rouatbi
Sonia Rouatbi

1 August 2021 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
MHmohamed haddad
mohamed haddad
VHVincent Hervé
Vincent Hervé
MKMohamed Raâfet Ben Khedher
Mohamed Raâfet Ben Khedher
JRJean-Michel Rabanel
Jean-Michel Rabanel
CRCharles Ramassamy
Charles Ramassamy
Significance: Glutathione (GSH) represents the most abundant and the main antioxidant in the body with important functions in the brain related to Alzheimer’s disease (AD). Recent Advances: Oxidative stress is one of the central mechanisms in AD. We and others have demonstrated the alteration of GSH in AD brain, its important role for the detoxification of advanced glycation end products and of acrolein. Recent in vivo studies found a decrease of GSH in different area of the brain from control, mild cognitive impairment and AD subjects which is correlated with cognitive functions. Critical Issues: Several strategies were developed to restore its intracellular level with the L-cysteine prodrugs or the oral administration of γ-glutamylcysteine (γ-GC) to prevent alterations observed in AD. To date, no benefit on GSH levels or oxidation biomarkers have been reported in clinical trials. Thus, it remains uncertain if GSH could be considered as a potential preventive or therapeutic approach or as a biomarker for AD. Future Directions: We will address how GSH-coupled nanocarriers represent a promising approach for the functionalization of nanocarriers to overcome the blood brain barriers (BBB) for the delivery of GSH to the brain while avoiding cellular toxicity. It is also important to address the presence of GSH in exosomes for its potential intercellular transfer or to cross the BBB under certain conditions.

6 March 2017 in EXCLI Journal
Verified
Journal Article
Open access
MKMed Raâfet Ben Khedher
Med Raâfet Ben Khedher
SKSaoussen Ben Khedher
Saoussen Ben Khedher
ICIkbal Chaieb
Ikbal Chaieb
STSlim Tounsi
Slim Tounsi
MHMohamed Hammami
Mohamed Hammami
The aim of this study is to evaluate the chemical composition, antioxidant, antimicrobial, insecticidal and allelopathic activities of Tunisia Salvia officinalis essential oil (SoEO). The SoEO was characterized by the presence of 49 components with camphor (25.14 %), α-thujone (18.83 %), 1,8-cineole (14.14 %), viridiflorol (7.98 %), β-thujone (4.46 %) and β-caryophyllene (3.30 %) as the major components, determined by gas chromatography-mass spectrometry. The level of antioxidant activity, determined by complementary tests, namely 2,2-diphenyl-1-picrylhydrazyl radical-scavenging (IC50= 6.7 mg/mL), linoleic acid peroxidation (IC50= 9.6 mg/mL) and ferric reducing assays (IC50= 28.4 mg/mL), was relatively moderate. The SoEO was also screened for its antimicrobial activity. Good to moderate inhibitions were recorded for most of tested microorganisms. It also exhibited important insecticidal activity against Spodoptera littoralis larvae and Tribolium castaneum adults with LC50 values of 55.99 and 97.43 µl/L air, respectively. The effect of the SoEO on seeds germination and growth showed different activities against radical and hypocotyl elongation of the tested species. These results suggest the potential use of the SoEO as natural antimicrobial preservative in cosmetic, pharmaceutical industry and in pest management.

1 December 2016 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
JHJawhar Hafsa
Jawhar Hafsa
KHKhaoula Mkadmini Hammi
Khaoula Mkadmini Hammi
MKMed Raâfet Ben Khedher
Med Raâfet Ben Khedher
MSMed Ali Smach
Med Ali Smach
BCBassem Charfeddine
Bassem Charfeddine
HMHatem Majdoub
Hatem Majdoub

9 January 2018 in PeerJ
Verified
Journal Article
Open access
PDF file
MKMohamed R. Ben Khedher
Mohamed R. Ben Khedher
MHMohamed Hammami
Mohamed Hammami
JAJonathan R.S. Arch
Jonathan R.S. Arch
DHDavid C. Hislop
David C. Hislop
DEDominic Eze
Dominic Eze
MZMohamed Sghaier Zaibi
Mohamed Sghaier Zaibi
Background: Salvia officinalis(sage) is a native plant to the Mediterranean region and has been used for a long time in traditional medicine for various diseases. We investigated possible anti-diabetic, anti-inflammatory and anti-obesity effects of sage methanol (MetOH) extract in a nutritional mouse model of obesity, inflammation and insulin resistance, as well as its effects on lipolysis and lipogenesis in 3T3-L1 cells.Methods: Diet-induced obese (DIO) mice were treated for five weeks with sage methanol extract (100 and 400 mg kg−1/day bid), or rosiglitazone (3 mg kg−1/day bid), as a positive control. Energy expenditure, food intake, body weight, fat mass, liver glycogen and lipid content were evaluated. Blood glucose, and plasma levels of insulin, lipids leptin and pro- and anti-inflammatory cytokines were measured throughout the experiment. The effects of sage MetOH extract on lipolysis and lipogenesis were testedin vitroin 3T3-L1 cells.Results: After two weeks of treatment, the lower dose of sage MetOH extract decreased blood glucose and plasma insulin levels during an oral glucose tolerance test (OGTT). An insulin tolerance test (ITT), performed at day 29 confirmed that sage improved insulin sensitivity. Groups treated with low dose sage and rosiglitazone showed very similar effects on OGTT and ITT. Sage also improved HOMA-IR, triglycerides and NEFA. Treatment with the low dose increased the plasma levels of the anti-inflammatory cytokines IL-2, IL-4 and IL-10 and reduced the plasma level of the pro-inflammatory cytokines IL-12, TNF-α, and KC/GRO. The GC analysis revealed the presence of two PPARs agonist in sage MetOH extract.In vitro, the extract reduced in a dose-related manner the accumulation of lipid droplets; however no effect on lipolysis was observed.Conclusions: Sage MetOH extract at low dose exhibits similar effects to rosiglitazone. It improves insulin sensitivity, inhibits lipogenesis in adipocytes and reduces inflammation as judged by plasma cytokines. Sage presents an alternative to pharmaceuticals for the treatment of diabetes and associated inflammation.

Verified
Journal Article
Open access
PDF file
MHmohamed haddad
mohamed haddad
MPMorgane Perrotte
Morgane Perrotte
MKMohamed Raâfet Ben Khedher
Mohamed Raâfet Ben Khedher
CDClément Demongin
Clément Demongin
ALAurélie Lepage
Aurélie Lepage
CRCharles Ramassamy
Charles Ramassamy
Methylglyoxal (MG) and glyoxal (GO) are suggested to be associated with the development of neurodegenerative pathologies. However, their peripheral levels in relation to cognitive decline and their effects on key factors in neuronal cells are poorly investigated. The aim of this study was to determine their serum levels in MCI (mild cognitive impairment) and Alzheimer’s disease (AD) patients, to analyze their effects on the neurotrophic and inflammatory factors, on neurodegenerative markers in neuronal cells and in neuronal derived-extracellular vesicles (nEVs). Our results show that MG and GO levels in serum, determined by HPLC, were higher in MCI. ROC (receiver-operating characteristic curves) analysis showed that the levels of MG in serum have higher sensitivity to differentiate MCI from controls but not from AD. Meanwhile, serum GO levels differentiate MCI from control and AD groups. Cells and nEVs levels of BDNF, PRGN, NSE, APP, MMP-9, ANGPTL-4, LCN2, PTX2, S100B, RAGE, Aβ peptide, pTau T181 and alpha-synuclein were quantified by luminex assay. Treatment of neuronal cells with MG or GO reduced the cellular levels of NSE, PRGN, APP, MMP-9 and ANGPTL-4 and the nEVs levels of BDNF, PRGN and LCN2. Our findings suggest that targeting MG and GO may be a promising therapeutic strategy to prevent or delay the progression of AD.